Eli Lilly & Co (LLY) - Other Revenue (DISCONTINUED) (I:ELCLFSLV)
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Other Revenue is at a current level of 314.60M, up from 275.30M last quarter and down from 494.80M one year ago. This is a change of 14.28% from last quarter and -36.42% from one year ago. |
|
Other Revenue refers to the total revenue generated by Eli Lilly & Co from sources other than its core business segments. This category includes revenue that doesn't fall under the specific descriptions of the company's major operating segments, such as pharmaceutical products, animal health products, and medical devices. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 314.60M |
| Latest Period | Jun 2023 |
| Last Updated | Sep 19 2023, 14:26 EDT |
| Average Growth Rate | 57.41% |
| Value from Last Quarter | 275.30M |
| Change from Last Quarter | 14.28% |
| Value from 1 Year Ago | 494.80M |
| Change from 1 Year Ago | -36.42% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| June 30, 2023 | 314.60M |
| March 31, 2023 | 275.30M |
| December 31, 2022 | 355.90M |
| September 30, 2022 | 746.00M |
| June 30, 2022 | 494.80M |
| March 31, 2022 | 1.923B |
| December 31, 2021 | 1.536B |
| September 30, 2021 | 637.60M |
| Date | Value |
|---|---|
| June 30, 2021 | 713.00M |
| March 31, 2021 | 1.243B |
| December 31, 2020 | 1.445B |
| September 30, 2020 | 526.40M |
| June 30, 2020 | 481.10M |
| March 31, 2020 | 640.10M |
| December 31, 2019 | 503.80M |
News
Basic Info
|
Eli Lilly & Co (LLY) - Other Revenue is at a current level of 314.60M, up from 275.30M last quarter and down from 494.80M one year ago. This is a change of 14.28% from last quarter and -36.42% from one year ago. |
|
Other Revenue refers to the total revenue generated by Eli Lilly & Co from sources other than its core business segments. This category includes revenue that doesn't fall under the specific descriptions of the company's major operating segments, such as pharmaceutical products, animal health products, and medical devices. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 314.60M |
| Latest Period | Jun 2023 |
| Last Updated | Sep 19 2023, 14:26 EDT |
| Average Growth Rate | 57.41% |
| Value from Last Quarter | 275.30M |
| Change from Last Quarter | 14.28% |
| Value from 1 Year Ago | 494.80M |
| Change from 1 Year Ago | -36.42% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |